GlassScriptPhysician profile
Hasan Syed
NPI 1881170322
$1,319.89
in general payments reported to CMS, 2019-2025
12 companies · $947 in 2025
The $947 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.94 · 2020: $11.92 · 2021: $11.09 · 2022: $41.26 · 2023: $84.83 · 2024: $196 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Education: $128 · Gift: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.68 |
| Education | $127.50 |
| Gift | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $242.57 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $195.00 | 2024-2025 | |
| Abbott Laboratories | $146.95 | 2022-2024 | Freestyle Libre 3 |
| Amgen INC. | $144.66 | 2025 | Tepezza |
| Lilly USA, LLC | $139.55 | 2019-2025 | |
| Dexcom, INC. | $127.79 | 2021-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Sequel Med Tech, LLC | $99.04 | 2025 | Twiist |
| Medtronic, INC. | $92.66 | 2025 | Minimed 780g |
| Axonics, INC. | $84.83 | 2023 | Axonics |
| Abbvie INC. | $22.84 | 2022 | |
| Medtronic Minimed, INC. | $12.08 | 2019 | |
| Novo Nordisk INC | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.